Patent · US Active

Glycosaminoglycans

US10245281B2 · kind B2 · utility

0Cited by
2References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 31, 2015
Grant dateApr 2, 2019
Priority date—
Expiry dateJul 1, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61L2300/412
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Heparan sulphate HS7 is disclosed, together with the use of HS7 in the growth and/or development and/or regeneration of tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.